- Research works
- 5 ▼ 58% vs 2018-21
- Citations
- 37 7.5 per fractional work
- Top-10% rate
- 7.5% all institutions 10.0%
- Open access
- 65% world 40%
- International
- 16% world 18%
Not ranked overall: Dnapta Biotecnologia (Brazil) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Dnapta Biotecnologia (Brazil) work in?
In all years, 41% of research at Dnapta Biotecnologia (Brazil) is in Life Sciences, 29% in Physical Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (24%), Medicine (24%), Engineering (16%). It does 1.3× the world's share of Life Sciences.
Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 11 fields, with their numbers
- Life Sciences240.8%
- Physical Sciences128.6%
- Engineering116.3%
- Chemistry06.1%
- Computer Science04.1%
- Chemical Engineering02.0%
- Health Sciences128.6%
- Medicine124.5%
- Veterinary04.1%
- Social Sciences02.0%
- Social Sciences02.0%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.4×. Every wedge is a field page.
All 6 fields, with their numbers
- Biochemistry, Genetics and Molecular Biology4.44×0 works
- Computer Science3.20×0 works
- Agricultural and Biological Sciences1.74×0 works
- Environmental Science1.43×0 works
- Medicine1.23×0 works
- Social Sciences0.98×0 works
Which research topics does Dnapta Biotecnologia (Brazil) publish most on?
By volume in 2022-now: Cancer Research and Treatments, Information Science and Libraries, Open Source Software Innovations and Bee Products Chemical Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Cancer Research and Treatments Biotechnology 0 works
- 2 Information Science and Libraries Information Systems 0 works
- 3 Open Source Software Innovations Computer Science Applications 0 works
- 4 Bee Products Chemical Analysis Insect Science 0 works
- 5 Redox biology and oxidative stress Molecular Biology 0 works
- 6 Knowledge Management and Sharing Communication 0 works
- 7 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 8 Radiopharmaceutical Chemistry and Applications Radiology, Nuclear Medicine and Imaging 0 works
- 9 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 0 works
- 10 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Dnapta Biotecnologia (Brazil)'s research output changed?
Output in 2022-2025 was 58% lower than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Dnapta Biotecnologia (Brazil) as a percentage of every work published that year, 0.0000069% in 2022.
Fractional works of Dnapta Biotecnologia (Brazil) over all fractional works that year. How the balance of science has shifted.
Other research institutions in São José do Rio Preto
- Faculdade de Medicina de São José do Rio Preto
- Centro Universitário de Rio Preto
- Hospital de Base
- Centro Universitário do Norte Paulista
- Faculdade Ceres
- Trouw Nutrition (Brazil)
- Instituto de Urologia e Nefrologia
- Instituto de Moléstias Cardiovasculares
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Dnapta Biotecnologia (Brazil). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.